D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 16,133 280 World Ranking 15978 National Ranking 822
Molecular Biology D-index 73 Citations 16,101 275 World Ranking 795 National Ranking 59

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Cancer

Christopher Baum mostly deals with Gene, Genetic enhancement, Transgene, Virology and Genetics. His Gene study frequently draws connections between related disciplines such as Cell biology. His Genetic enhancement study combines topics from a wide range of disciplines, such as Molecular biology, Leukemia, Severe combined immunodeficiency and Transfection.

In his study, Bioinformatics is strongly linked to Hematopoietic stem cell transplantation, which falls under the umbrella field of Transgene. His study connects Viral vector and Virology. Christopher Baum works mostly in the field of Genetics, limiting it down to concerns involving Computational biology and, occasionally, Biosafety and Somatic cell.

His most cited work include:

  • Murine leukemia induced by retroviral gene marking. (589 citations)
  • Side effects of retroviral gene transfer into hematopoietic stem cells (385 citations)
  • Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors (310 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Genetic enhancement, Haematopoiesis, Molecular biology, Stem cell and Viral vector. His studies deal with areas such as Transgene, Vector and Immunology as well as Genetic enhancement. His research in Haematopoiesis intersects with topics in Progenitor cell, CD34, Cancer research and Bone marrow.

His Molecular biology study deals with Long terminal repeat intersecting with Enhancer. His study in Stem cell is interdisciplinary in nature, drawing from both In vivo and Transplantation. The various areas that Christopher Baum examines in his Viral vector study include Transduction, splice and Virology.

He most often published in these fields:

  • Genetic enhancement (46.67%)
  • Haematopoiesis (40.63%)
  • Molecular biology (38.73%)

What were the highlights of his more recent work (between 2010-2021)?

  • Haematopoiesis (40.63%)
  • Genetic enhancement (46.67%)
  • Cell biology (19.68%)

In recent papers he was focusing on the following fields of study:

Christopher Baum spends much of his time researching Haematopoiesis, Genetic enhancement, Cell biology, Molecular biology and Immunology. Christopher Baum combines subjects such as CD34, Cancer research and Bone marrow with his study of Haematopoiesis. His Genetic enhancement research includes themes of Viral vector, Severe combined immunodeficiency and Transduction.

His Viral vector research is multidisciplinary, incorporating perspectives in Gene expression profiling and Virology. As part of one scientific family, Christopher Baum deals mainly with the area of Molecular biology, narrowing it down to issues related to the Transgene, and often Exon. His work deals with themes such as Hematopoietic stem cell transplantation and Transplantation, which intersect with Immunology.

Between 2010 and 2021, his most popular works were:

  • A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency (262 citations)
  • Lentiviral Vector Design and Imaging Approaches to Visualize the Early Stages of Cellular Reprogramming (185 citations)
  • Gammaretroviral vectors: biology, technology and application. (142 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Cancer

Christopher Baum mostly deals with Haematopoiesis, Immunology, Virology, Genetic enhancement and Genetics. The study incorporates disciplines such as Transduction and Bone marrow in addition to Haematopoiesis. His work on Leukemia as part of general Immunology research is frequently linked to Diamond–Blackfan anemia, thereby connecting diverse disciplines of science.

His Virology research is multidisciplinary, incorporating elements of Progenitor cell, Viral vector and Transplantation. Genetic enhancement is a subfield of Gene that he investigates. His work in Genetics addresses issues such as Computational biology, which are connected to fields such as Biosafety and Pseudotyping.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Murine leukemia induced by retroviral gene marking.

Zhixiong Li;Zhixiong Li;Jochen Düllmann;Bernd Schiedlmeier;Manfred Schmidt.
Science (2002)

799 Citations

Side effects of retroviral gene transfer into hematopoietic stem cells

Christopher Baum;Jochen Düllmann;Zhixiong Li;Boris Fehse.
Blood (2003)

520 Citations

Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors

Ute Modlich;Susana Navarro;Daniela Zychlinski;Tobias Maetzig.
Molecular Therapy (2009)

418 Citations

Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors.

Christopher Baum;Olga Kustikova;Ute Modlich;Zhixiong Li.
Human Gene Therapy (2006)

391 Citations

A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency

Salima Hacein-Bey-Abina;Sung Yun Pai;H. Bobby Gaspar;Myriam Armant.
The New England Journal of Medicine (2014)

388 Citations

Clonal Dominance of Hematopoietic Stem Cells Triggered by Retroviral Gene Marking

Olga Kustikova;Boris Fehse;Ute Modlich;Min Yang.
Science (2005)

382 Citations

Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity

Ute Modlich;Jens Bohne;Manfred Schmidt;Christof von Kalle.
Blood (2006)

367 Citations

Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.

C Baum;S Hegewisch-Becker;H G Eckert;C Stocking.
Journal of Virology (1995)

343 Citations

Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene Vectors

Daniela Zychlinski;Axel Schambach;Ute Modlich;Tobias Maetzig.
Molecular Therapy (2008)

329 Citations

Chance or necessity? Insertional mutagenesis in gene therapy and its consequences

Christopher Baum;Christof von Kalle;Frank J.T Staal;Zhixiong Li.
Molecular Therapy (2003)

298 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Christopher Baum

Axel Schambach

Axel Schambach

Hannover Medical School

Publications: 213

Adrian J. Thrasher

Adrian J. Thrasher

University College London

Publications: 134

Hans Peter Kiem

Hans Peter Kiem

Fred Hutchinson Cancer Research Center

Publications: 91

Wolfgang Uckert

Wolfgang Uckert

Max Delbrück Center for Molecular Medicine

Publications: 66

Donald B. Kohn

Donald B. Kohn

University of California, Los Angeles

Publications: 66

Boris Fehse

Boris Fehse

Universität Hamburg

Publications: 64

David A. Williams

David A. Williams

Boston Children's Hospital

Publications: 62

Dirk Lindemann

Dirk Lindemann

TU Dresden

Publications: 53

Michel Sadelain

Michel Sadelain

Memorial Sloan Kettering Cancer Center

Publications: 46

Alain Fischer

Alain Fischer

Collège de France

Publications: 46

Fulvio Mavilio

Fulvio Mavilio

University of Modena and Reggio Emilia

Publications: 45

Dorothee von Laer

Dorothee von Laer

Innsbruck Medical University

Publications: 45

Cynthia E. Dunbar

Cynthia E. Dunbar

National Institutes of Health

Publications: 45

Manfred Schmidt

Manfred Schmidt

German Cancer Research Center

Publications: 40

Luigi Naldini

Luigi Naldini

Vita-Salute San Raffaele University

Publications: 40

Marina Cavazzana-Calvo

Marina Cavazzana-Calvo

Necker-Enfants Malades Hospital

Publications: 39

Trending Scientists

Reiko Heckel

Reiko Heckel

University of Leicester

Martin Cooke

Martin Cooke

Ikerbasque

Inessa Love

Inessa Love

University of Hawaii at Manoa

Andreas Stemmer

Andreas Stemmer

ETH Zurich

Jagjit Nanda

Jagjit Nanda

Oak Ridge National Laboratory

Johanna Döbereiner

Johanna Döbereiner

Brazilian Agricultural Research Corporation

Michael J. Garabedian

Michael J. Garabedian

New York University

Gerd Fätkenheuer

Gerd Fätkenheuer

University of Cologne

Bernadette M. Sloyan

Bernadette M. Sloyan

CSIRO Marine and Atmospheric Research

Tatiana Tkatch

Tatiana Tkatch

Northwestern University

Thomas Blankenstein

Thomas Blankenstein

Max Delbrück Center for Molecular Medicine

Marshall Schminke

Marshall Schminke

University of Central Florida

William H. Rogers

William H. Rogers

Tufts Medical Center

Maurizio Trevisan

Maurizio Trevisan

Università Campus Bio-Medico di Roma

Peter Hohenberger

Peter Hohenberger

Heidelberg University

Rosario Samanin

Rosario Samanin

Mario Negri Institute for Pharmacological Research

Something went wrong. Please try again later.